Budesonide in Patients With Immune Mediated Enteropathies

Clinical Trial ID NCT03866538

Rank	Title	Journal	Year	PubWeight™‹?›
1	The Oslo definitions for coeliac disease and related terms.	Gut	2012	5.76
2	Oral budesonide for active Crohn's disease. Canadian Inflammatory Bowel Disease Study Group.	N Engl J Med	1994	2.52
3	Etiologies and predictors of diagnosis in nonresponsive celiac disease.	Clin Gastroenterol Hepatol	2007	1.82
4	Classification and management of refractory coeliac disease.	Gut	2010	1.48
5	Oral budesonide is as effective as oral prednisolone in active Crohn's disease. The Global Budesonide Study Group.	Gut	1997	1.30
6	Budesonide CIR capsules (once or twice daily divided-dose) in active Crohn's disease: a randomized placebo-controlled study in the United States.	Am J Gastroenterol	2002	0.83
7	Less Hidden Celiac Disease But Increased Gluten Avoidance Without a Diagnosis in the United States: Findings From the National Health and Nutrition Examination Surveys From 2009 to 2014.	Mayo Clin Proc	2016	0.81
8	Creation of a model to predict survival in patients with refractory coeliac disease using a multinational registry.	Aliment Pharmacol Ther	2016	0.77
9	Open-Capsule Budesonide for Refractory Celiac Disease.	Am J Gastroenterol	2017	0.75